beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial (2018)
Source: European journal of gastroenterology & hepatology. Unidade: FM
Subjects: CIRROSE HEPÁTICA, CARDIOPATIAS, HIPERTENSÃO PORTAL, RATOS, ESTUDOS RANDOMIZADOS, BETA-BLOQUEADORES
ABNT
SILVESTRE, Odilson M.; FARIAS, Alberto Q.; CARRILHO, Flair J.; ALBUQUERQUE, Luiz A. C. beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial. European journal of gastroenterology & hepatology, Philadelphia, v. 30, n. 8, p. 930-937, 2018. Disponível em: < http://dx.doi.org/10.1097/MEG.0000000000001128 > DOI: 10.1097/MEG.0000000000001128.APA
Silvestre, O. M., Farias, A. Q., Carrilho, F. J., & Albuquerque, L. A. C. (2018). beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial. European journal of gastroenterology & hepatology, 30( 8), 930-937. doi:10.1097/MEG.0000000000001128NLM
Silvestre OM, Farias AQ, Carrilho FJ, Albuquerque LAC. beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial [Internet]. European journal of gastroenterology & hepatology. 2018 ; 30( 8): 930-937.Available from: http://dx.doi.org/10.1097/MEG.0000000000001128Vancouver
Silvestre OM, Farias AQ, Carrilho FJ, Albuquerque LAC. beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial [Internet]. European journal of gastroenterology & hepatology. 2018 ; 30( 8): 930-937.Available from: http://dx.doi.org/10.1097/MEG.0000000000001128